Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Biosenic | BIOS | May 14, 2024 | 0.01 | -2.70 |
Biotalys | BTLS | May 14, 2024 | 2.80 | -5.72 |
Boeing | BOEI | May 14, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | May 14, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | May 14, 2024 | 3.44 | -0.43 |
Brederode S.A. | BREB | May 14, 2024 | 115.20 | +1.95 |
Campine nv | CAMB | May 14, 2024 | 76.00 | 0.00 |
Candela Invest | CAND | May 14, 2024 | 2.80 | 0.00 |
Care Property Invest NV/SA | CPINV | May 14, 2024 | 14.46 | -0.55 |
Celyad Oncology SA | CYAD | May 14, 2024 | 0.30 | -0.97 |
Cenergy Holdings | CENER | May 14, 2024 | 8.25 | -0.60 |
Chevron | CHTEX | May 14, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | May 14, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | May 14, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | May 14, 2024 | 60.25 | +0.08 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | May 14, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | May 14, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | May 14, 2024 | 43.10 | -0.37 |
Compagnie du Bois Sauvage S.A. | COMB | May 14, 2024 | 264.00 | +0.76 |
Compagnie d`Entreprises CFE SA | CFEB | May 14, 2024 | 7.68 | -2.17 |
Connect Group | CONN | May 14, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | May 14, 2024 | 0.01 | 0.00 |
Cumulex NV | CLEX | May 14, 2024 | 1.15 | 0.00 |
CURETIS | CURE | May 14, 2024 | 0.29 | 0.00 |
Deceuninck NV. | DECB | May 14, 2024 | 2.50 | +0.60 |
Deme Group N.V. | DEME | May 14, 2024 | 161.80 | +4.93 |
Deutsche Telekom AG | DTEL | May 14, 2024 | 20.00 | 0.00 |
Dexia SA | DEXB | May 14, 2024 | 0.30 | 0.00 |
Diegem KennedyCert | DIEG | May 14, 2024 | 123.00 | 0.00 |
Distri Land Le Certificat Foncier | DISL | May 14, 2024 | 210.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.